# muscular (blogs) — RSS Amplifier Recent posts from the 4 feeds in the RSS Amplifier directory that cover muscular. Page: Feed: --- ## [Looking for Work? Want to Help Give Away Billions of Dollars?](https://david293.substack.com/p/looking-for-work-want-to-help-give-151) _2026-08-17 · David Jensen · The California Stem Cell Report_ CIRM has two new job openings, including one for an AI whiz. ## [Capricor Stock Jumps 59 Percent as Firm Maneuvers to Win Approval of Duchenne Treatment](https://david293.substack.com/p/capricor-stock-jumps-59-percent-as) _2026-08-13 · David Jensen · The California Stem Cell Report_ California taxpayers backing firm with $18 million ## [Update on the FDA’s Review of Deramiocel: Continuing the Path Forward](https://www.parentprojectmd.org/update-on-the-fdas-review-of-deramiocel-continuing-the-path-forward/) _2026-08-13 · Parent Project Muscular Dystrophy · Parent Project Muscular Dystrophy_ Today, Capricor Therapeutics shared an important update on the FDA’s review of the Biologics License Application (BLA) for Deramiocel, the company’s cell therapy for the treatment of Duchenne muscular dystrophy-associated cardiomyopathy. Capricor has indicated that... The post Update on the FDA’s Review of Deramiocel: Continuing the Path Forward appeared first on Parent Project Muscular Dystrophy… ## [LinkedIn Video, Transparency, Accessibility: The View from the Stem Cell Trenches at CIRM](https://david293.substack.com/p/linkedin-video-transparency-accessibility) _2026-08-11 · David Jensen · The California Stem Cell Report_ An infectious video involving the transparency of a California state biomedical research organization, whose 17,000-word genome rarely inspires influencers, caught my attention recently. ## [Capricor in Trouble with Feds But California Stands Apart from the Ruckus Despite $18 Million Taxpayer Investment. Why?](https://david293.substack.com/p/capricor-in-trouble-with-feds-but) _2026-08-06 · David Jensen · The California Stem Cell Report_ Here is the answer from the Golden State's stem cell and gene therapy program, which has a longterm interest in the program. ## [Political Media Tackle $12 Billion California Ballot Measure for Immunology Research](https://david293.substack.com/p/political-media-begins-look-at-12) _2026-08-04 · David Jensen · The California Stem Cell Report_ Not identical to the California stem cell and gene therapy agency, also a $12 billion enterprise, but some similarities ## [Capricor Committed to Winning Federal Go-Ahead on Treatment for Deadly Affliction that Attacks Boys and Young Men](https://david293.substack.com/p/capricor-committed-to-winning-federal) _2026-07-30 · David Jensen · The California Stem Cell Report_ California backing company with $18 million ## [Capricor's Treatment for Deadly Muscle-Wasting Disease Rebuffed by FDA Advisory Committee](https://david293.substack.com/p/capricors-treatment-for-deadly-muscle) _2026-07-29 · David Jensen · The California Stem Cell Report_ 15,000 boys and young men affected nationwide; California has millions of dollars riding on the Duchenne therapy ## [Thank You for Raising Your Voices During the Deramiocel FDA Advisory Committee Meeting](https://www.parentprojectmd.org/thank-you-for-raising-your-voices-during-the-deramiocel-fda-advisory-committee-meeting/) _2026-07-29 · Parent Project Muscular Dystrophy · Parent Project Muscular Dystrophy_ Today, the FDA’s Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) met to discuss Capricor Therapeutics’ Biologics License Application (BLA) for Deramiocel as a potential treatment for Duchenne muscular dystrophy (Duchenne). Following a full day... The post Thank You for Raising Your Voices During the Deramiocel FDA Advisory Committee Meeting appeared first on Parent Project… ## [FDA-Capricor Hearing: Patients Tell a Story of Loss and Unstoppable Muscle Deterioration](https://david293.substack.com/p/fda-capricor-hearing-patients-tell) _2026-07-29 · David Jensen · The California Stem Cell Report_ Holding a pencil, feeding themselves and dignity are major goals for patients ## [Marketplace for AI-Powered Professionals (Sponsored)](https://crawlproof.com/a/EpOsZU7E5TkB) _2026-07-29 · **Sponsored**_ Find professionals who use ChatGPT, Copilot, and Claude to deliver work faster. ## [Capricor-FDA Hearing: Public to be Heard Next, Vote on Capricor May Come by Midafternoon](https://david293.substack.com/p/capricor-fda-hearing-public-to-be) _2026-07-29 · David Jensen · The California Stem Cell Report_ The FDA-Capricor hearing in Maryland is beginning its afternoon session after a lunch break. ## [FDA Capricor Hearing: Company Says Lightning Does Not Strike Three Times in Same Place](https://david293.substack.com/p/fda-capricor-hearing-company-says) _2026-07-29 · David Jensen · The California Stem Cell Report_ Consistent favorable results not coincidental ## [Ahead of the July 29 Advisory Committee: We Urge the FDA to Consider the Totality of Evidence](https://www.parentprojectmd.org/ahead-of-the-july-29-advisory-committee-we-urge-the-fda-to-consider-the-totality-of-evidence/) _2026-07-28 · Parent Project Muscular Dystrophy · Parent Project Muscular Dystrophy_ On July 29th, 2026, the FDA will convene an Advisory Committee meeting to evaluate Deramiocel, Capricor Therapeutics’ investigational therapy for Duchenne muscular dystrophy. These meetings are an important step in the regulatory process, bringing together... The post Ahead of the July 29 Advisory Committee: We Urge the FDA to Consider the Totality of Evidence appeared first on Parent Project… ## [What to Know Ahead of This Week’s Deramiocel FDA Advisory Committee Meeting](https://www.parentprojectmd.org/what-to-know-ahead-of-this-weeks-deramiocel-fda-advisory-committee-meeting/) _2026-07-27 · Parent Project Muscular Dystrophy · Parent Project Muscular Dystrophy_ On Wednesday, July 29, 2026, the FDA’s Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) will meet to review Capricor Therapeutics’ Biologics License Application (BLA) for Deramiocel as a potential treatment for Duchenne. The meeting... The post What to Know Ahead of This Week’s Deramiocel FDA Advisory Committee Meeting appeared first on Parent Project Muscular Dystrophy . ## [PPMD Honored with RAPS 2026 Patient-Centered Health Award](https://www.parentprojectmd.org/ppmd-honored-with-raps-2026-patient-centered-health-award/) _2026-07-22 · Parent Project Muscular Dystrophy · Parent Project Muscular Dystrophy_ PPMD is honored to receive the 2026 Patient-Centered Health Award from the Regulatory Affairs Professionals Society (RAPS), recognizing organizations that have made significant contributions to advancing patient-centered healthcare and ensuring patient perspectives inform the development... The post PPMD Honored with RAPS 2026 Patient-Centered Health Award appeared first on Parent Project Muscular… ## [FDA Accepts Dyne Therapeutics’ Biologics License Application for Z-Rostudirsen](https://www.parentprojectmd.org/fda-accepts-dyne-therapeutics-biologics-license-application-for-z-rostudirsen/) _2026-07-20 · Parent Project Muscular Dystrophy · Parent Project Muscular Dystrophy_ Today, Dyne Therapeutics announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics License Application (BLA) for zeleciment rostudirsen (z-rostudirsen) for the treatment of individuals living with Duchenne muscular dystrophy who... The post FDA Accepts Dyne Therapeutics’ Biologics License Application for Z-Rostudirsen appeared first on Parent Project Muscular… ## [Highlights from PPMD’s 2026 Annual Conference](https://www.parentprojectmd.org/highlights-from-ppmds-2026-annual-conference/) _2026-07-10 · Parent Project Muscular Dystrophy · Parent Project Muscular Dystrophy_ Whether you joined us in Orlando or are catching up from home, the learning opportunities from PPMD’s 2026 Annual Conference continue. We’re excited to share that recordings and resources from PPMD’s 2026 Annual Conference are... The post Highlights from PPMD’s 2026 Annual Conference appeared first on Parent Project Muscular Dystrophy . ## [Preparing for the Deramiocel FDA Advisory Committee Meeting: How to Submit Written Testimony](https://www.parentprojectmd.org/preparing-for-the-deramiocel-fda-advisory-committee-meeting-how-to-submit-written-testimony/) _2026-07-07 · Parent Project Muscular Dystrophy · Parent Project Muscular Dystrophy_ The FDA has scheduled an Advisory Committee meeting for July 29, 2026 to review Deramiocel, Capricor’s investigational cell therapy for Duchenne muscular dystrophy. The meeting will be held in person with the option to participate... The post Preparing for the Deramiocel FDA Advisory Committee Meeting: How to Submit Written Testimony appeared first on Parent Project Muscular Dystrophy . ## [FDA Accepts sNDAs to Review Traditional Approval for AMONDYS 45 and VYONDYS 53](https://www.parentprojectmd.org/fda-accepts-sndas-to-review-traditional-approval-for-amondys-45-and-vyondys-53/) _2026-06-30 · Parent Project Muscular Dystrophy · Parent Project Muscular Dystrophy_ Today, Sarepta Therapeutics announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental New Drug Applications (sNDAs) seeking traditional approval for AMONDYS 45® (casimersen) and VYONDYS 53® (golodirsen). The FDA will... The post FDA Accepts sNDAs to Review Traditional Approval for AMONDYS 45 and VYONDYS 53 appeared first on Parent Project Muscular Dystrophy… ## [Watch chovy live code (Sponsored)](https://crawlproof.com/a/qtk4PbMC9Iwf) _2026-06-30 · **Sponsored**_ Join Mosh Coding streams with collaborative screen sharing and remote control, open source. ## [Catching Up on PPMD’s 2026 Annual Conference: Part II](https://www.parentprojectmd.org/catching-up-on-ppmds-2026-annual-conference-part-ii/) _2026-06-27 · Parent Project Muscular Dystrophy · Parent Project Muscular Dystrophy_ PPMD’s 2026 Annual Conference brought together individuals and families from across the Duchenne and Becker community for three days filled with scientific presentations, discussions around care, clinical trials and quality of life, and of course,... The post Catching Up on PPMD’s 2026 Annual Conference: Part II appeared first on Parent Project Muscular Dystrophy .